UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$205M |
| 2 |
Johnson & Johnson
JNJ
|
+$186M |
| 3 |
Honeywell
HON
|
+$177M |
| 4 |
Mondelez International
MDLZ
|
+$132M |
| 5 |
Alibaba
BABA
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$270M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$212M |
| 3 |
Citigroup
C
|
+$185M |
| 4 |
Booking.com
BKNG
|
+$104M |
| 5 |
Intuitive Surgical
ISRG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 14.47% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGI
1201
Somnigroup International
SGI
$14B
| $2.61M | ﹤0.01% |
188,680
+4,320
| +2% | +$63.7K |
|
1202
Integra LifeSciences
IART
$1.39B
| $2.6M | ﹤0.01% |
65,328
-18,852
| -22% | -$678K |
|
1203
Brinker International
EAT
$9.66B
| $2.6M | ﹤0.01% |
57,025
+3,409
| +6% | +$156K |
|
1204
Unifirst Corp
UNF
$5.27B
| $2.58M | ﹤0.01% |
22,263
-5,143
| -19% | -$575K |
|
|
RPT
1205
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.57M | ﹤0.01% |
131,198
+7,355
| +6% | +$133K |
|
|
ALE
1206
DELISTED
Allete
ALE
| $2.57M | ﹤0.01% |
39,804
+395
| +1% | +$22.8K |
|
1207
Globus Medical
GMED
$11.1B
| $2.56M | ﹤0.01% |
107,592
-2,925
| -3% | -$70.2K |
|
1208
Spire
SR
$4.73B
| $2.56M | ﹤0.01% |
36,084
+697
| +2% | +$45.8K |
|
1209
Crane NXT
CXT
$3.09B
| $2.55M | ﹤0.01% |
129,451
+1,154
| +0.9% | +$22.5K |
|
1210
Federated Hermes
FHI
$4.77B
| $2.55M | ﹤0.01% |
88,562
+12,231
| +16% | +$374K |
|
1211
Fair Isaac
FICO
$22.6B
| $2.54M | ﹤0.01% |
22,484
+170
| +0.8% | +$18.4K |
|
|
GWR
1212
DELISTED
Genesee & Wyoming Inc.
GWR
| $2.53M | ﹤0.01% |
42,941
| – | – |
|
1213
Nu Skin
NUS
$251M
| $2.53M | ﹤0.01% |
54,786
+3,665
| +7% | +$148K |
|
1214
Vanguard Morningstar Large-Cap ETF
VV
$54.2B
| $2.52M | ﹤0.01% |
26,346
+5,493
| +26% | +$521K |
|
1215
Encompass Health
EHC
$11.2B
| $2.52M | ﹤0.01% |
81,622
+985
| +1% | +$30.8K |
|
|
MSCC
1216
DELISTED
Microsemi Corp
MSCC
| $2.52M | ﹤0.01% |
77,160
+2,149
| +3% | +$73.6K |
|
1217
Euronet Worldwide
EEFT
$2.8B
| $2.5M | ﹤0.01% |
36,117
+5,027
| +16% | +$383K |
|
|
ARMH
1218
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $2.5M | ﹤0.01% |
54,855
-5,001
| -8% | -$211K |
|
|
CRC
1219
DELISTED
California Resources Corporation
CRC
| $2.47M | ﹤0.01% |
202,696
+56,540
| +39% | +$899K |
|
1220
NorthWestern Energy
NWE
$4.3B
| $2.45M | ﹤0.01% |
38,842
-208
| -0.5% | -$12.3K |
|
1221
MKS Inc
MKSI
$20.9B
| $2.45M | ﹤0.01% |
56,856
+24,106
| +74% | +$936K |
|
1222
uniQure
QURE
$3.06B
| $2.45M | ﹤0.01% |
332,209
-13,194
| -4% | -$158K |
|
|
PEI
1223
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $2.45M | ﹤0.01% |
7,609
+278
| +4% | +$92K |
|
|
NYRT
1224
DELISTED
New York REIT, Inc.
NYRT
| $2.45M | ﹤0.01% |
26,434
+1,250
| +5% | +$121K |
|
1225
Rithm Capital
RITM
$5.62B
| $2.44M | ﹤0.01% |
176,528
+1,689
| +1% | +$21.7K |
|
Similar funds
UBS AM's Q2 2016 Portfolio in Review
As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
- UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
- UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
- UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
- UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
- UBS AM opened 65 new positions and closed 89 in Q2 2016.
- UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.